Cited by 3,738PI3K/AKT/mTOR signaling in cancerProtein Kinase Regulation and GTPase SignalingMetabolism, Diabetes, and Cancer

The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.

Oncogenic kinase signalling.

Blume-Jensen, Peter, Hunter, Tony·2001·Nature

DOI 10.1038/35077225

Open this paper in CoChat — free account

Abstract

Protein-tyrosine kinases (PTKs) are important regulators of intracellular signal-transduction pathways mediating development and multicellular communication in metazoans. Their activity is normally tightly controlled and regulated. Perturbation of PTK signalling by mutations and other genetic alterations results in deregulated kinase activity and malignant transformation. The lipid kinase phosphoinositide 3-OH kinase (PI(3)K) and some of its downstream targets, such as the protein-serine/threonine kinases Akt and p70 S6 kinase (p70S6K), are crucial effectors in oncogenic PTK signalling. This review emphasizes how oncogenic conversion of protein kinases results from perturbation of the normal autoinhibitory constraints on kinase activity and provides an update on our knowledge about the role of deregulated PI(3)K/Akt and mammalian target of rapamycin/p70S6K signalling in human malignancies.

Integrity signals

Registry

Crossref · 10.1038/35077225

Cites

93 of 93 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The hallmarks of cancer
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Cell Signaling by Receptor Tyrosine Kinases
Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
Druker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J., Lydon, N., Kantarjian, H. M., Capdeville, R., Ohno-Jones, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441401 · Cited by 5,237
Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors
Hirota, S., Isozaki, K., Moriyama, Y., Hashimoto, K., Nishida, T., Ishiguro, S., Kawano, K., Hanada, M., Kurata, A., Takeda, M., et al. (1998) · Science · doi:10.1126/science.279.5350.577 · Cited by 4,487
Cellular survival: a play in three Akts
Datta, S. R., Brunet, A., & Greenberg, M. E. (1999) · Genes & Development · doi:10.1101/gad.13.22.2905 · Cited by 4,216
STATs and Gene Regulation
Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
Cell Signaling by Receptor Tyrosine Kinases
Schlessinger, J. (2000) · Cell · doi:10.1016/s0092-8674(00)00114-8 · Cited by 3,774
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells
Druker, B. J., Tamura, S., Buchdunger, E., Ohno-Jones, S., Segal, G. M., Fanning, S., Zimmermann, J., & Lydon, N. (1996) · Nature Medicine · doi:10.1038/nm0596-561 · Cited by 3,652
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
Druker, B. J., Sawyers, C. L., Kantarjian, H., Resta, D. J., Reese, S. F., Ford, J. M., Capdeville, R., & Talpaz, M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441402 · Cited by 2,713
Signaling—2000 and Beyond
Hunter, T. (2000) · Cell · doi:10.1016/s0092-8674(00)81688-8 · Cited by 2,586
Self-citation

Flagged first, then by citations

Show all 93 references

Research works printed but not linked: 3

Blume-Jensen, P. & Hunter, T. in Encyclopedia of Cancer (ed. Bertino, J. R.) (Academic, San Diego, in the press).
Blume-Jensen, P. & Hunter, T. in Cancer Research - An Encyclopedic Reference (ed. Schwab, M.) (Springer, in the press).
Blume-Jensen, P. & Hunter, T. in Encyclopedia of Cancer (ed. Bertino, J. R.) (Academic, San Diego, in the press).

Sorted by citations

Items 301–400 of 1,008

Primary cilia and coordination of receptor tyrosine kinase (RTK) signalling
Christensen, S. T., Clement, C. A., Satir, P., & Pedersen, L. B. (2012) · The Journal of Pathology · doi:10.1002/path.3004 · Cited by 181
Structure and Content of the Entamoeba histolytica Genome
Clark, C. G., Alsmark, U. C. M., Tazreiter, M. H., Saito‐Nakano, Y., Ali, V., Marion, S., Weber, C., Mukherjee, C., Bruchhaus, I., Tannich, E., et al. (2007) · Advances in Parasitology/Advances in parasitology · doi:10.1016/s0065-308x(07)65002-7 · Cited by 188
Optimization of Protein Kinase CK2 Inhibitors Derived from 4,5,6,7-Tetrabromobenzimidazole
Pagano, M. A., Andrzejewska, M., Ruzzene, M., Sarno, S., Cesaro, L., Bain, J., Elliott, M., Meggio, F., Kazimierczuk, Z., & Pinna, L. A. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049854a · Cited by 185
FOXM1 (Forkhead box M1) in Tumorigenesis
Wierstra, I. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-407190-2.00016-2 · Cited by 190
Proline cis-trans Isomerization Controls Autoinhibition of a Signaling Protein
Sarkar, P., Reichman, C., Saleh, T., Birge, R. B., & Kalodimos, C. G. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.01.004 · Cited by 189
Functional map and domain structure of MET, the product of the c- met protooncogene and receptor for hepatocyte growth factor/scatter factor
Gherardi, E., Youles, M. E., Miguel, R. N., Blundell, T. L., Iamele, L., Gough, J., Bandyopadhyay, A., Hartmann, G., & Butler, P. J. G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2034936100 · Cited by 183
Activation of Akt (PKB) and suppression of FKHRL1 in mouse and rat oocytes by stem cell factor during follicular activation and development
Reddy, P., Shen, L., Ren, C., Boman, K., Lundin, E., Ottander, U., Lindgren, P., Liu, Y., Sun, Q., & Liu, K. (2005) · Developmental Biology · doi:10.1016/j.ydbio.2005.02.013 · Cited by 183
PHLiPPing the switch on Akt and protein kinase C signaling
Brognard, J., & Newton, A. C. (2008) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2008.04.001 · Cited by 186
The role of Src in prostate cancer
Fizazi, K. S. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm086 · Cited by 184
Recent developments in epigenetic cancer therapeutics: clinical advancement and emerging trends
Nepali, K., & Liou, J. (2021) · Journal of Biomedical Science · doi:10.1186/s12929-021-00721-x · Cited by 187
Lactate Engages Receptor Tyrosine Kinases Axl, Tie2, and Vascular Endothelial Growth Factor Receptor 2 to Activate Phosphoinositide 3-Kinase/Akt and Promote Angiogenesis
Ruan, G.-X., & Kazlauskas, A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.474619 · Cited by 192
Something old, something new and something borrowed: emerging paradigm of insulin-like growth factor type 1 receptor (IGF-1R) signaling regulation
Girnita, L., Worrall, C., Takahashi, S., Seregard, S., & Girnita, A. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1514-y · Cited by 184
Peptidyl-prolyl cis–trans isomerase Pin1 in ageing, cancer and Alzheimer disease
Lee, T. H., Pastorino, L., & Lu, K. P. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411001906 · Cited by 185
Imaging Epidermal Growth Factor Receptor Expression In vivo : Pharmacokinetic and Biodistribution Characterization of a Bioconjugated Quantum Dot Nanoprobe
Diagaradjane, P., Orenstein-Cardona, J. M., Colón-Casasnovas, N. E., Deorukhkar, A., Shentu, S., Kuno, N., Schwartz, D. L., Gelovani, J. G., & Krishnan, S. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1958 · Cited by 181
Phosphoproteomics in cancer
Gowda, H., & Pandey, A. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.09.004 · Cited by 177
Main roads to melanoma
Palmieri, G., Capone, M., Ascierto, M. L., Gentilcore, G., Stroncek, D. F., Casula, M., Sini, M. C., Palla, M., Mozzillo, N., & Ascierto, P. A. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-86 · Cited by 190
MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia
Gao, X.-N., Lin, J.-Y., Yh, L., Gao, L., Wang, X.-R., Wang, W., Kang, H.-Y., Yan, G.-T., Wang, L., & Yu, L. (2011) · Oncogene · doi:10.1038/onc.2011.62 · Cited by 182
The integrin—growth factor receptor duet
Alam, N., Goel, H. L., Zarif, M. J., Butterfield, J. E., Perkins, H. M., Sansoucy, B. G., Sawyer, T. K., & Languino, L. R. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21278 · Cited by 178
From the mathematical kinetic, and stochastic game theory to modelling mutations, onset, progression and immune competition of cancer cells
Bellomo, N., & Delitala, M. E. (2008) · Physics of Life Reviews · doi:10.1016/j.plrev.2008.07.001 · Cited by 177
Characterization of the expression of the ALK receptor tyrosine kinase in mice
Vernersson, E., Khoo, N. K. S., Henriksson, M. L., Roos, G., Palmer, R. H., & Hallberg, B. (2006) · Gene Expression Patterns · doi:10.1016/j.modgep.2005.11.006 · Cited by 177
Regulation of an Activated S6 Kinase 1 Variant Reveals a Novel Mammalian Target of Rapamycin Phosphorylation Site
Saitoh, M., Pullen, N., Brennan, P., Cantrell, D. A., Dennis, P. B., & Thomas, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201745200 · Cited by 177
Structural and Functional Properties of Platelet-Derived Growth Factor and Stem Cell Factor ReceptorsPreprint
Heldin, C., & Lennartsson, J. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009100 · Cited by 171
Tyrosine Phosphorylation Profiling Reveals the Signaling Network Characteristics of Basal Breast Cancer Cells
Hochgräfe, F., Zhang, L., O'Toole, S. A., Browne, B. C., Pinese, M., Cubas, A. P., Lehrbach, G. M., Croucher, D. R., Rickwood, D., Boulghourjian, A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0911 · Cited by 181
Hyaluronan Constitutively Regulates Activation of Multiple Receptor Tyrosine Kinases in Epithelial and Carcinoma Cells
Misra, S., Toole, B. P., & Ghatak, S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c600138200 · Cited by 174
In vivo Target Modulation and Biological Activity of CHIR-258, a Multitargeted Growth Factor Receptor Kinase Inhibitor, in Colon Cancer Models
Lee, S. H., Menezes, D. L. D., Vora, J., Harris, A. L., Ye, H., Nordahl, L., Garrett, E. N., Samara, E. E., Aukerman, S. L., Gelb, A. B., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2129 · Cited by 174
Minireview: RET: Normal and Abnormal Functions
Santoro, M., Melillo, R. M., Carlomagno, F., Vecchio, G., & Fusco, A. (2004) · Endocrinology · doi:10.1210/en.2004-0922 · Cited by 172
Tyrosine kinase oncogenes in normal hematopoiesis and hematological disease
Scheijen, B., & Griffin, J. D. (2002) · Oncogene · doi:10.1038/sj.onc.1205317 · Cited by 173
Prolyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer
Ryo, A., Liou, Y., Lu, K. P., & Wulf, G. M. (2003) · Journal of Cell Science · doi:10.1242/jcs.00276 · Cited by 172
Boron-Based Drug Design
Ban, H. S., & Nakamura, H. (2015) · The Chemical Record · doi:10.1002/tcr.201402100 · Cited by 170
Inhibition of ALK Signaling for Cancer Therapy
Mossé, Y. P., Wood, A., & Maris, J. M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2762 · Cited by 176
Protein Tyrosine Phosphorylation and Reversible Oxidation: Two Cross-Talking Posttranslation Modifications
Chiarugi, P., & Buricchi, F. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.9.1 · Cited by 172
Drug resistance, predictive markers and pharmacogenomics in colorectal cancer
Longley, D. B., Allen, W. L., & Johnston, P. G. (2006) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.08.001 · Cited by 173
Chemoresistance in solid tumours
Wilson, T. R., Longley, D. B., & Johnston, P. G. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl280 · Cited by 176
A Structurally-Validated Multiple Sequence Alignment of 497 Human Protein Kinase Domains
Modi, V., & Dunbrack, R. L. (2019) · Scientific Reports · doi:10.1038/s41598-019-56499-4 · Cited by 171
The Ras/Mitogen-Activated Protein Kinase Pathway Inhibitor and Likely Tumor Suppressor Proteins, Sprouty 1 and Sprouty 2 Are Deregulated in Breast Cancer
Lo, T. L., Yusoff, P., Fong, C. W., Guo, K., McCaw, B. J., Phillips, W. A., He, Y., Wong, E. S. M., Leong, H. F., Zeng, Q., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1207 · Cited by 171
Redox regulation of protein kinases
Truong, T. H., & Carroll, K. S. (2013) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.790873 · Cited by 182
In-depth Qualitative and Quantitative Profiling of Tyrosine Phosphorylation Using a Combination of Phosphopeptide Immunoaffinity Purification and Stable Isotope Dimethyl Labeling
Boersema, P. J., Foong, L. Y., Ding, V., Lemeer, S., van Breukelen, B., Philp, R. J., Boekhorst, J., Snel, ‎., den Hertog, J., Choo, A. B. H., et al. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900291-mcp200 · Cited by 170
Inhibition of phosphatidylinositol 3-kinase-Akt signaling blocks growth, promotes apoptosis, and enhances sensitivity of small cell lung cancer cells to chemotherapy.
Krystal, G. W., Sulanke, G., & Litz, J. (2002) · PubMed · Cited by 170
Syk-dependent mTOR activation in follicular lymphoma cells
Leseux, L., Hamdi, S. M., Saati, T. A., Capilla, F., Récher, C., Laurent, G., & Bezombes, C. (2006) · Blood · doi:10.1182/blood-2006-05-026203 · Cited by 171
ETV6–NTRK3: a chimeric protein tyrosine kinase with transformation activity in multiple cell lineages
Lannon, C. L., & Sorensen, P. H. B. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.01.003 · Cited by 166
Phosphatidylinositol 3-kinase/Akt signaling as a key mediator of tumor cell responsiveness to radiation
Toulany, M., & Rodemann, H. P. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.07.003 · Cited by 174
FKHR (FOXO1a) is required for myotube fusion of primary mouse myoblasts
Bois, P. R. J., & Grosveld, G. C. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg116 · Cited by 168
Receptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancers
Ségaliny, A. I., Tellez-Gabriel, M., Heymann, M.-F., & Heymann, D. (2015) · Journal of Bone Oncology · doi:10.1016/j.jbo.2015.01.001 · Cited by 164
Current strategies and findings in clinically relevant post-translational modification-specific proteomics
Pagel, O., Loroch, S., Sickmann, A., & Zahedi, R. P. (2015) · Expert Review of Proteomics · doi:10.1586/14789450.2015.1042867 · Cited by 163
EGFR: An essential receptor tyrosine kinase-regulator of cancer stem cells
Talukdar, S., Emdad, L., Das, S. K., & Fisher, P. B. (2020) · Advances in cancer research · doi:10.1016/bs.acr.2020.04.003 · Cited by 165
Mutations in STAP1 Are Associated With Autosomal Dominant Hypercholesterolemia
Fouchier, S. W., Dallinga‐Thie, G. M., Meijers, J. C. M., Zelcer, N., Kastelein, J. J. P., Defesche, J. C., & Hovingh, G. K. (2014) · Circulation Research · doi:10.1161/circresaha.115.304660 · Cited by 163
Physical biology of the cancer cell glycocalyx
Kuo, J. C., Gandhi, J. G., Zia, R. N., & Paszek, M. J. (2018) · Nature Physics · doi:10.1038/s41567-018-0186-9 · Cited by 165
Imatinib mesylate affects the development and function of dendritic cells generated from CD34+ peripheral blood progenitor cells
Appel, S., Boehmler, A. M., Grünebach, F., Müller, M., Rupf, A., Weck, M. M., Hartmann, U., Reichardt, V. L., Kanz, L., Brümmendorf, T. H., et al. (2003) · Blood · doi:10.1182/blood-2003-03-0975 · Cited by 163
Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives as EGFR TK inhibitors and potential anticancer agents
Lv, P., Li, D., Li, Q., Lu, X., Xiao, Z., & Zhu, H. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.07.010 · Cited by 162
Pathway-Based Identification of Biomarkers for Targeted Therapeutics: Personalized Oncology with PI3K Pathway Inhibitors
Andersen, J. N., Sathyanarayanan, S., Bacco, A. D., Chi, A., Zhang, T., Chen, A. H., Dolinski, B. M., Kraus, M., Roberts, B. S., Arthur, W. T., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001065 · Cited by 164
Self-citation
Nimbolide-Induced Oxidative Stress Abrogates STAT3 Signaling Cascade and Inhibits Tumor Growth in Transgenic Adenocarcinoma of Mouse Prostate Model
Zhang, J., Ahn, K. S., Kim, C., Shanmugam, M. K., Siveen, K. S., Arfuso, F., Samy, R. P., Deivasigamanim, A., Lim, L. H. K., Wang, L., et al. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6418 · Cited by 162
New insights about the PDGF/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies
Pandey, P., Khan, F., Upadhyay, T. K., Moon, S., Park, M. N., & Kim, B. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114491 · Cited by 171
A FRET-Based Assay Platform for Ultra-High Density Drug Screening of Protein Kinases and Phosphatases
Rodems, S. M., Hamman, B. D., Lin, C. M., Zhao, J. Y., Shah, S., Heidary, D. K., Makings, L., Stack, J. H., & Pollok, B. A. (2002) · Assay and Drug Development Technologies · doi:10.1089/154065802761001266 · Cited by 162
Insulin‐like growth factor‐1 regulates the SIRT 1‐p53 pathway in cellular senescence
Tran, D., Bergholz, J., Zhang, H., He, H., Wang, Y., Zhang, Y., Li, Q., Kirkland, J. L., & Xiao, Z. (2014) · Aging Cell · doi:10.1111/acel.12219 · Cited by 161
“IGF signaling plays a mitogenic role; activation of the IGF1R leads to upregulation of the PI3K/AKT pathway, thus increasing cell survival and promoting growth and proliferation (Blume-Jensen & Hunter, 2001).”
Background
Characterization of potent inhibitors of the Bcr-Abl and the c-kit receptor tyrosine kinases.
Wisniewski, D. J., Lambek, C. L., Liu, C., Strife, A., Veach, D. R., Nagar, B., Young, M. A., Schindler, T. H., Bornmann, W. G., Bertino, J. R., et al. (2002) · PubMed · Cited by 161
Feedback and redundancy in receptor tyrosine kinase signaling: relevance to cancer therapies
Sun, C., & Bernards, R. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.08.010 · Cited by 155
Knowledge Based Prediction of Ligand Binding Modes and Rational Inhibitor Design for Kinase Drug Discovery
Ghose, A. K., Herbertz, T., Pippin, D. A., Salvino, J. M., & Mallamo, J. P. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800475y · Cited by 166
Genotoxicity and Cytotoxicity of Zinc Oxide and Titanium Dioxide in HEp-2 Cells
Osman, I. F., Baumgartner, A., Cemeli, E., Fletcher, J. N., & Anderson, D. C. (2010) · Nanomedicine · doi:10.2217/nnm.10.52 · Cited by 163
Phosphorylation-dependent interaction between antigenic peptides and MHC class I: a molecular basis for the presentation of transformed self
Mohammed, F., Cobbold, M., Zarling, A. L., Salim, M., Barrett-Wilt, G. A., Shabanowitz, J., Hunt, D. F., Engelhard, V. H., & Willcox, B. E. (2008) · Nature Immunology · doi:10.1038/ni.1660 · Cited by 155
Resveratrol modulation of signal transduction in apoptosis and cell survival: A mini-review
Fulda, S., & Debatin, K. (2006) · Cancer Detection and Prevention · doi:10.1016/j.cdp.2006.03.007 · Cited by 158
Protein Tyrosine Phosphorylation and Protein Tyrosine Nitration in Redox Signaling
Monteiro, H. P., Arai, R. J., & Travassos, L. R. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1853 · Cited by 158
Targeting DNA Double-Strand Break Repair Pathways to Improve Radiotherapy Response
Toulany, M. (2019) · Genes · doi:10.3390/genes10010025 · Cited by 164
Mixed signals in heart failure: cancer rules
Hoshijima, M., & Chien, K. R. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15380 · Cited by 162
Biological Role of Anaplastic Lymphoma Kinase in Neuroblastoma
Osajima-Hakomori, Y., Miyake, I., Ohira, M., Nakagawara, A., Nakagawa, A., & Sakai, R. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62966-5 · Cited by 158
Toward the rational design of protein kinase casein kinase-2 inhibitors
Sarno, S., Moro, S., Meggio, F., Zagotto, G., Ben, D. D., Ghisellini, P., Battistutta, R., Zanotti, G., & Pinna, L. A. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00185-7 · Cited by 156
Brk Activates Rac1 and Promotes Cell Migration and Invasion by Phosphorylating Paxillin
Chen, H., Shen, C., Tsai, Y.-T., Lin, F.-C., Huang, Y.-P., & Chen, R. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10558-10572.2004 · Cited by 154
Kinomics: characterizing the therapeutically validated kinase space
Vieth, M., Sutherland, J. J., Robertson, D. H., & Campbell, R. M. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03477-x · Cited by 155
Functions of PI 3‐kinase in development of the nervous system
Rodgers, E. E., & Theibert, A. B. (2002) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(02)00047-3 · Cited by 154
Molecular analysis of the PI3K‐AKT pathway in uterine cervical neoplasia: Frequent PIK3CA amplification and AKT phosphorylation
Bertelsen, B. I., Steine, S. J., Sandvei, R., Molven, A., & Lærum, O. D. (2005) · International Journal of Cancer · doi:10.1002/ijc.21461 · Cited by 153
Peroxisome Proliferator–Activated Receptor α Activation Decreases Metastatic Potential of Melanoma Cells In vitro via Down-Regulation of Akt
Grabacka, M., Plonka, P. M., Urbańska, K., & Reiss, K. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2556 · Cited by 153
Bioorthogonal Chemical Activation of Kinases in Living Systems
Zhang, G., Li, J., Xie, R., Fan, X., Liu, Y., Zheng, S., Ge, Y., & Chen, P. R. (2016) · ACS Central Science · doi:10.1021/acscentsci.6b00024 · Cited by 153
A comparative study of molecular mutations in 381 patients with myelodysplastic syndrome and in 4130 patients with acute myeloid leukemia
Bacher, U., Haferlach, T., Kern, W., Haferlach, C., & Schnittger, S. (2007) · Haematologica · doi:10.3324/haematol.10869 · Cited by 150
Developmental Immunology and Role of Host Defenses in Fetal and Neonatal Susceptibility to Infection
Lewis, D. B., & Wilson, C. B. (2006) · Elsevier eBooks · doi:10.1016/b0-72-160537-0/50006-2 · Cited by 151
Entrectinib: a potent new TRK, ROS1, and ALK inhibitor
Rolfo, C. D., Ruiz, R., Giovannetti, E., Bazo, I. G., Russo, A. D., Passiglia, F., Giallombardo, M., Peeters, M., & Raez, L. E. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.1096344 · Cited by 152
Vascular cell senescence and vascular aging
Minamino, T., Miyauchi, H., Yoshida, T., Tateno, K., Kunieda, T., & Komuro, I. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2003.11.010 · Cited by 153
Minireview: Alternative Activation Pathways for the Androgen Receptor in Prostate Cancer
Lamont, K. R., & Tindall, D. J. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0469 · Cited by 150
Crystal Structure of the MuSK Tyrosine Kinase
Till, J. H., Becerra, M., Watty, A., Lu, Y., Ma, Y., Neubert, T. A., Burden, S. J., & Hubbard, S. R. (2002) · Structure · doi:10.1016/s0969-2126(02)00814-6 · Cited by 150
Electroporated DNA Vaccine Clears Away Multifocal Mammary Carcinomas in Her-2/neuTransgenic Mice
Quaglino, E., Iezzi, M., Mastini, C., Amici, A. R. D., Pericle, F., Carlo, E. D., Pupa, S. M., Giovanni, C. D., Spadaro, M., Curcio, C., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2962 · Cited by 150
Phosphorylation stabilizes Nanog by promoting its interaction with Pin1
Moretto-Zita, M., Jin, H., Shen, Z., Zhao, T., Briggs, S. P., & Xu, Y. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005847107 · Cited by 149
Lowered oxygen tension induces expression of the hypoxia marker MN/carbonic anhydrase IX in the absence of hypoxia-inducible factor 1 alpha stabilization: a role for phosphatidylinositol 3'-kinase.
Kaluz, Š., Kaluzová, M., Chrastina, A., Olive, P. L., Pastoreková, S., Pastorek, J., Lerman, M. I., & Stanbridge, E. J. (2002) · PubMed · Cited by 149
ReviewPTPs versus PTKs: The redox side of the coin
Chiarugi, P. (2005) · Free Radical Research · doi:10.1080/10715760400027987 · Cited by 155
Biologically Driven Synthesis of Pyrazolo[3,4-d]pyrimidines As Protein Kinase Inhibitors: An Old Scaffold As a New Tool for Medicinal Chemistry and Chemical Biology Studies
Schenone, S., Radi, M., Musumeci, F., Brullo, C., & Botta, M. (2014) · Chemical Reviews · doi:10.1021/cr400270z · Cited by 148
Targeting Transcription Factors for Cancer Gene Therapy
Libermann, T. A., & Zerbini, L. F. (2006) · Current Gene Therapy · doi:10.2174/156652306775515501 · Cited by 153
Augmentor α and β (FAM150) are ligands of the receptor tyrosine kinases ALK and LTK: Hierarchy and specificity of ligand–receptor interactions
Reshetnyak, A. V., Murray, P. B., Shi, X., Mo, E. S., Mohanty, J., Tomé, F., Bai, H., Günel, M., Lax, I., & Schlessinger, J. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520099112 · Cited by 148
Proposed mechanisms of (−)-epigallocatechin-3-gallate for anti-obesity
Moon, H., Lee, H.-G., Choi, Y.-J., Kim, T. G., & Cho, C.-S. (2007) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2007.02.008 · Cited by 147
Regulation of breast cancer cell chemotaxis by the phosphoinositide 3-kinase p110delta.
Sawyer, C., Sturge, J., Bennett, D. C., O’Hare, M. J., Allen, W. E., Bain, J., Jones, G. E., & Vanhaesebroeck, B. (2003) · PubMed · Cited by 147
Not just for housekeeping: protein initiation and elongation factors in cell growth and tumorigenesis
Thornton, S., Anand, N., Purcell, D., & Lee, J. W. J. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0461-8 · Cited by 147
A General Strategy for Creating “Inactive-Conformation” Abl Inhibitors
Barun, O., Nagle, A. S., Adrián, F., Lee, C. R., Ren, P., Wang, X., Sim, T., Xie, Y., Wang, X., Xia, G., et al. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.05.015 · Cited by 147
Loss of E-cadherin activates EGFR-MEK/ERK signaling, which promotes invasion via the ZEB1/MMP2 axis in non-small cell lung cancer
Bae, G.-Y., Choi, S., Lee, J., Jo, J., Lee, J., Kim, J., & Cha, H. (2013) · Oncotarget · doi:10.18632/oncotarget.1463 · Cited by 147
Synergistic effect between EGF and TGF-β1 in inducing oncogenic properties of intestinal epithelial cells
Uttamsingh, S., Bao, X., Nguyen, K. T., Bhanot, M., Gong, J., Chan, J., Liu, F., Chu, T.-Y., & Wang, L. (2007) · Oncogene · doi:10.1038/sj.onc.1210915 · Cited by 146
Activation of Ras/Erk Pathway by a Novel MET-interacting Protein RanBPM
Wang, D., Li, Z., Messing, E. M., & Wu, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205111200 · Cited by 142
Human Immunodeficiency Virus 1 Envelope Glycoprotein Complex-Induced Apoptosis Involves Mammalian Target of Rapamycin/Fkbp12-Rapamycin–Associated Protein–Mediated P53 Phosphorylation
Castedo, M., Ferri, K. F., Blanco, J., Roumier, T., Larochette, N., Barretina, J. G., Amendola, A., Nardacci, R., Métivier, D., Esté, J. A., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.8.1097 · Cited by 145
Phosphatidylinositol 3-Kinase Inhibition Broadly Sensitizes Glioblastoma Cells to Death Receptor– and Drug-Induced Apoptosis
Opel, D., Westhoff, M., Bender, A., Braun, V., Debatin, K., & Fulda, S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6769 · Cited by 146
Evolvable signaling networks of receptor tyrosine kinases: relevance of robustness to malignancy and to cancer therapy
Amit, I., Wides, R., & Yarden, Y. (2007) · Molecular Systems Biology · doi:10.1038/msb4100195 · Cited by 147
Transactivation of Epidermal Growth Factor Receptor by G Protein-Coupled Receptors: Recent Progress, Challenges and Future Research
Wang, Z. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17010095 · Cited by 148
Tyrosine kinase inhibitors enhanced the efficacy of conventional chemotherapeutic agent in multidrug resistant cancer cells
Wu, S., & Fu, L. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0775-3 · Cited by 145
K252a inhibits the oncogenic properties of Met, the HGF receptor
Morotti, A., Mila, S., Accornero, P., Tagliabue, E., & Ponzetto, C. (2002) · Oncogene · doi:10.1038/sj.onc.1205622 · Cited by 149
The PTEN-AKT3 signaling cascade as a therapeutic target in melanoma
Madhunapantula, S. V., & Robertson, G. P. (2009) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2009.00585.x · Cited by 148
EGF receptor activation by GPCRs: An universal pathway reveals different versions
Liebmann, C. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.04.008 · Cited by 143
Degradation of Activated Protein Kinases by Ubiquitination
Zhi-min, L., & Tony, H. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.013008.092711 · Cited by 145

Authors: Blume-Jensen, P., & Hunter, T.
Affiliations: Salk Institute for Biological Studies (US)
ORCID: Hunter, Tony
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2001-05-01
Volume: 411
Issue: 6835
Pages: 355-365
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/35077225
OpenAlex: W1639582946
Cited by: 3,738
References: 93
Citations by year: 2026: 48 · 2025: 69 · 2024: 87 · 2023: 102 · 2022: 103 · 2021: 114 · 2020: 121 · 2019: 118 · 2018: 105 · 2017: 119 · 2016: 131 · 2015: 156 · 2014: 186 · 2013: 185 · 2012: 200
FWCI: 12.95
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords: tyrosine kinase, oncogenic signaling, signal transduction, phosphatidylinositol 3-kinase, Akt, p70 S6 kinase, mTOR, kinase autoinhibition, malignant transformation, human malignancies
MeSH terms: Animals, Humans, Mutation, Neoplasms, Oncogenes, Protein-Tyrosine Kinases, Signal Transduction, Oncogene Proteins, Retroviridae Proteins, Oncogenic, Phosphatidylinositol 3-Kinases, Ribosomal Protein S6 Kinases, Receptor Protein-Tyrosine Kinases, Oncogene Protein v-akt

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Oncogenic kinase signalling.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks